| Ytd | -96.96% | |
| 1y | -99.77% |
| Open | 0.76 | Prev Close | 0.76 | Low | 0.75 | High | 0.84 | Mkt Cap | 16.34M |
| Vol | 0.00 | Avg Vol | 136.54K | EPS | -2.90 | P/E | -0.29 | Forward P/E | -0.90 |
| Beta | -2.14 | Short Ratio | 1.91 | Inst. Own | 48.13% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-08 | 50-d Avg | 1.66 | 200-d Avg | 17.13 | 1yr Est | 15.00 |
KALA News
KALA BIO (NASDAQ: KALA - Get Free Report) is anticipated to release its Q2 2026 results before the m
ARLINGTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ: KALA) (“KALA BIO” or the
ARLINGTON, Mass., April 21, 2026 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ: KALA) (“KALA” or the “C
Undervalued companies in health care sector with low RSI values present buying opportunity: PepGen I
Celularity (NASDAQ: CELU - Get Free Report) and KALA BIO (NASDAQ: KALA - Get Free Report) are both s
Engagement will assess KALA's clinical assets, development options, and AI-enabled analytical opport
Next-Generation Agentic AI Platform Achieves Live Enterprise Deployment, Delivering Secure, Scalable
The company confirmed that BIRA is now live in client-controlled environments, marking its entry int
KALA BIO, Inc. (NASDAQ: KALA - Get Free Report) has been given a consensus recommendation of "Hold"
AI-powered autonomous research agents to be deployed in support of PEX010 clinical development strat
AI-powered autonomous research agents to be deployed in support of PEX010 clinical development strat
U.S. stock futures fall 250 points, Highpeak Energy shares drop 7%. Other stocks also down in pre-ma
U.S. stock futures fall 250 points, Highpeak Energy shares drop 7%. Other stocks also down in pre-ma
Open-source breakthrough demonstrates AI agents can run 100+ experiments overnight-reinforcing the a
Platform Rebrand of Researgency.ai; First Purpose-Built AI Agent for Biotech Expected to Ship Within
Younet AI Partners with KALA BIO to Deploy AI Infrastructure for the Biotech Industry Vancouver, Bri
KALA BIO (KALA) shares rose after unveiling a strategic initiative to build an on-premises AI infras
ARLINGTON, Mass., March 04, 2026 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ: KALA) (“KALA” or the “C
KALA BIO, Inc. (NASDAQ: KALA - Get Free Report) has been given an average recommendation of "Hold" b
KALA BIO (NASDAQ: KALA) held its 2025 annual meeting of stockholders in a virtual format, with Chief
ARLINGTON, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), (“KALA” or the “Co
ARLINGTON, Mass., Dec. 04, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA) (“KALA” or the “Com
KALA BIO shares jumped over 22% after Oxford Finance acquired a 16.5% stake, amid recent leadership
Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The comp
Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders look
On Tuesday, 298 companies achieved new lows for the year.
On Thursday, 241 companies hit new 52-week lows.
On Wednesday, 115 stocks hit new 52-week lows.